Literature DB >> 16695060

STUDIES ON THE PLASMA PROTEINS. V. THE EFFECT OF CONCENTRATED SOLUTIONS OF HUMAN AND BOVINE SERUM ALBUMIN ON BLOOD VOLUME AFTER ACUTE BLOOD LOSS IN MAN.

J T Heyl1, J G Gibson, C A Janeway, A Shwachman, L Wojcik.   

Abstract

Entities:  

Year:  1943        PMID： 16695060      PMCID： PMC435293          DOI： 10.1172/JCI101449

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  3 in total

1.  CLINICAL STUDIES OF THE BLOOD VOLUME. I. CLINICAL APPLICATION OF A METHOD EMPLOYING THE AZO DYE "EVANS BLUE" AND THE SPECTROPHOTOMETER.

Authors:  J G Gibson; W A Evans
Journal:  J Clin Invest       Date:  1937-05       Impact factor: 14.808

2.  CLINICAL STUDIES OF THE BLOOD VOLUME. IV. ADAPTATION OF THE METHOD TO THE PHOTOELECTRIC MICROCOLORIMETER.

Authors:  J G Gibson; K A Evelyn
Journal:  J Clin Invest       Date:  1938-03       Impact factor: 14.808

3.  THE RELATION OF POSTURAL HEMODILUTION TO PAROXYSMAL DYSPNEA.

Authors:  G A Perera; R W Berliner
Journal:  J Clin Invest       Date:  1943-01       Impact factor: 14.808
  3 in total
  18 in total

1.  The effect of acute hypovolemia on the release of aldosterone and on the renal excretion of sodium.

Authors:  D FINE; L E MEISELAS; T AUERBACH
Journal:  J Clin Invest       Date:  1958-02       Impact factor: 14.808

2.  THE MEASUREMENT OF THE CIRCULATING RED CELL VOLUME BY MEANS OF TWO RADIOACTIVE ISOTOPES OF IRON.

Authors:  J G Gibson; S Weiss; R D Evans; W C Peacock; J W Irvine; W M Good; A F Kip
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

3.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VI. THE OSMOTIC PRESSURE OF PLASMA AND OF SERUM ALBUMIN.

Authors:  G Scatchard; A C Batchelder; A Brown
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

4.  CIRCULATING RED CELL VOLUME MEASURED SIMULTANEOUSLY BY THE RADIOACTIVE IRON AND DYE METHODS.

Authors:  J G Gibson; W C Peacock; A M Seligman; T Sack
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

5.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. IX. THE TREATMENT OF SHOCK WITH CONCENTRATED HUMAN SERUM ALBUMIN: A PRELIMINARY REPORT.

Authors:  J V Warren; E A Stead; A J Merrill; E S Brannon
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

6.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VII. CONCENTRATED HUMAN SERUM ALBUMIN.

Authors:  C A Janeway; S T Gibson; L M Woodruff; J T Heyl; O T Bailey; L R Newhouser
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

7.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXI. THE USE OF SALT-POOR CONCENTRATED HUMAN SERUM ALBUMIN SOLUTION IN THE TREATMENT OF HEPATIC CIRRHOSIS.

Authors:  G W Thorn; S H Armstrong; V D Davenport
Journal:  J Clin Invest       Date:  1946-05       Impact factor: 14.808

8.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION XXX. THE USE OF SALT-POOR CONCENTRATED HUMAN SERUM ALBUMIN SOLUTION IN THE TREATMENT OF CHRONIC BRIGHT'S DISEASE.

Authors:  G W Thorn; S H Armstrong; V D Davenport; L M Woodruff; F H Tyler
Journal:  J Clin Invest       Date:  1945-11       Impact factor: 14.808

9.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. VIII. CLINICAL USE OF CONCENTRATED HUMAN SERUM ALBUMIN IN SHOCK, AND COMPARISON WITH WHOLE BLOOD AND WITH RAPID SALINE INFUSION.

Authors:  A Cournand; R P Noble; E S Breed; H D Lauson; E de F Baldwin; G B Pinchot; D W Richards
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

10.  Pure Serum Albumin Compared with Citrated Plasma in the Therapy of Chronic Hypoalbuminemia.

Authors:  R Elman; F J Kelly; D H Simonsen
Journal:  Ann Surg       Date:  1948-08       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.